MENU
IMAB
AS OF
Jan 17 closing price
Price
$1.07
Change
-$0.03 (-2.73%)
Capitalization
87.21M
66 days until earnings call
IMAB
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$1.07
Change
-$0.03 (-2.73%)
Capitalization
87.21M
IMAB I-MAB Chart, History Price & Graph
a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.
Industry Biotechnology
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
IMAB and Stocks
Correlation & Price change
A.I.dvisor tells us that IMAB and CTMX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMAB and CTMX's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To IMAB | 1D Price Change % | ||
|---|---|---|---|---|
| IMAB | 100% | -2.73% | ||
| CTMX - IMAB | 32% Poorly correlated | -0.84% | ||
| RPRX - IMAB | 31% Poorly correlated | -0.65% | ||
| SANA - IMAB | 27% Poorly correlated | -2.77% | ||
| AVTE - IMAB | 27% Poorly correlated | +6.17% | ||
| LGND - IMAB | 27% Poorly correlated | +0.73% | ||
More | ||||